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The technique of '09Cd-based X-ray fluorescence (XRF) measurements of lead in bone is well
established. A paper by some XRF researchers [Gordon CL, et al. The Reproducibility of109Cd
based X-ray Fluorescence Measurements of Bone Lead. Environ Health Perspect 102:690-694
(1994)] presented the currently practiced method for calculating the varie ofan in vivomea-
surement once a calibration line has been establshed. This paper corrects typographical errors in
the method published by those authors; presents a crude estmte ofthe measurement error that
can be acquiredwithoutcomputationalpeakfittingprograms; anddrawsattention to the measure-
ment errorattributable tocovariance, animportant featureintheconstructofthecurrentl accept-
ed method that is flawed under certain circumstaces. Kiy work bone, lead, mesurement error,
X-rayfluorescence. EnvironHelthPepctc 108:383-386 (2000). [Online 15 March 1999]
htp://e/rpnetl.niehs.nih.gov/doc/2000/108p383-386todd/abstrac.tnl
The in vivo measurement oflead in human
bone using 109Cd-based fluorescence of the
K-shell X-rays of lead (KXRF) is a well-
established technique that has been widely
applied to studies of the human health
effects of lead and has been reviewed, most
recently, by Todd and Chettle (1) in a tech-
nical manner and by Hu et al. (2) in a con-
ceptual manner. This paper addresses the
method for calculating the measurement
uncertainty in a bone-lead measurement
given in a 1994 paper byGordon et al. (3).
In 109Cd-based KXRF, the 88.034 keV
7-rays from 109Cd are used to fluoresce the
K-shell X-rays oflead (in increasing energy,
those with Siegbahn notation: Ka2, Ka1,
K41, KP3, and KP2). The 109Cdy-rays can
also elastically scatter offofthe calcium and
phosphorus (and, to a lesser extent, oxygen)
atoms in bone and inelastically scatter offall
of the elements in the sample undergoing
measurement (principally the bone, soft tis-
sue, and skin). The photons are recorded by
a spectroscopy system that yields an energy
distribution ofthe recorded photons that is
then fitted using a nonlinear least-squares
technique with a mathematical function to
extract the amplitudes ofthe X-ray and elas-
tic scatter peaks. The ratio of the X-ray-to-
elastic peaks is the response of the system
and is regressed, for each X-ray peak under
analysis, against the lead concentration of
the calibration standards to produce a cali-
bration line.
The in vivo signal from a subject is mea-
sured for each lead X-ray to be analyzed and
is compared to the established calibration
line to obtain one or more estimates of the
subject's bone-lead level. The individual X-
ray estimates are then combined, usually in
an inverse-variance weighted manner, to
produce the result.
The remainder of this paper addresses
methods for the mathematical treatment of
the measurement uncertainty; corrects typo-
graphical errors in the published method of
Gordon et al. (3); presents a crude estimate
of the measurement error that can be
acquired without computational peak-fitting
programs; and addresses the measurement
errorattributable to covariance.
Materials and Methods
Gordon et al. (3) published a study of the
reproducibility of109Cd-based X-ray fluores-
cence (XRF) measurements of bone lead.
Their paper contained an "Appendix"
wherein they gave a near-complete descrip-
tion of the mathematical method by which
they calculated the variance of an in vivo
bone-lead measurement. In brief, they made
multiple measurements ofa series ofplaster-
of-paris phantoms doped with a range of
lead concentrations. The spectrum of scat-
tered radiation showed characteristic peaks
from the emission oflead KX-rays that var-
ied in size depending, in part, on the lead
concentration ofthe phantom. Gordon et al.
used four of the lead K X-rays for analysis:
those with Siegbahn (International Union of
Pure and Applied Chemistry notation in
parentheses) Kul (K-L3), Ku2 (K-L2), Kil
(K-M3), and K,3 (K-M2). For clarity and
ease ofcomparison, I will use the notation of
Gordon et al.: xi denotes the amplitude of
each X-ray peak, coh denotes the coherent
peak amplitude, and RJ denotes the ratio of
the two peak amplitudes. Peak amplitudes
and SDs are extracted from the spectra by
applying a nonlinear least-squares technique.
A calibration line is constructed for the ratio
of the X-ray-to-coherent peak amplitudes
against lead concentration. The ratio is used
because it is independent, to agood approxi-
mation, of two important factors that affect
in vivoand phantom measurements; namely,
source-to-skin distance and overlying tissue
thickness. Each calibration line is calculated
using least-squares regression. I perform
weightedleast-squares regression and I suspect
that Gordon et al. did also, although they did
not state what method they used. However,
the method ofleast-squares regression is irrel-
evant to thearguments ofthis paper.
Regression gives estimates ofthe calibra-
tion line slope (mi), the slope's variance
(a2A), the intercept (C), the intercept's vari-
ance (aci), and the covariance between the
slope and intercept (Gcimi). The X-ray-to-
coherent ratios from an in vivo measurement
can be converted, using the calibration lines,
into estimates of the in vivo lead concen-
tration (Pbi). A matrix correction term
accounts for the difference between phan-
tom (plaster-of-paris) and human (bone)
matrices, and the estimates of the in vivo
bone-lead concentration are combined into
an inverse-variance weighted mean to give a
single estimate (Pb,,). The inverse-variance
weighted estimate has a variance that is
denoted cypbP'
For each ofthe leadX-rays in use
R. -Ci Pbi = 1A46 ' , [Gordon 1]
mi
where 1.46 is "the ratio ofcoherent scattering
cross-sections of bone mineral to hydrated
plaster ofparis at 88 keVand 160` (3) and
coh' [Gordon 2]
Thevariance ofthe ratio, a2 , is given by
2 xi ~~~~~~~~~~~+ aco xi,
{(x,) coh I}Lcoh
[Gordon 3]
An expression for "a crude underestimate of
the measurement variance a (3), which
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ignores the calibration line uncertainties, is
given by
2
2pb = (1.46)2U
mi [Gordon 4]
Gordon et al. then gave two expressions for
the inverse-variance weighted mean (Pb )
and the variance thereof(aP2b.) derived from
the individual leadX-raypeakestimates:
Pb
2
Pb, = , [Gordon 5]
2
iCPbi
which has a
obtained from an inverse-variance weighted
mean ofthe estimates from each ofthe lead
X-rays considered. The final term inside the
bracket ofGordon Equation 8,
2
CUcoh x2
coh X
2 2
miwi
should be
22 2
C c.h x (i
tcoh) coh)
m2 2
giving a corrected version of Gordon
Equation 8 of
variance of 2
a-2
( < [Gordon6] yb.= 1.462 Co )4 +
Discussion
Crud estimates ofmeasurement error. The
crude estimate of measurement error given
by Gordon et al. (Equation Gordon 4) can
be simplified into a form that can be
obtained at the time of measurement
("online") and with slightly less computa-
tional effort than the estimate ofGordon et
al. A cruder estimate of measurement error
can be obtained by using the fact that the
variance of the X-ray peak amplitude (or
area) dominates the variance of the ratio of
the X-ray to coherent peak amplitudes (or
areas). The fractional error in the ratio is
therefore approximately equal to the frac-
tional error in theX-raypeak:
a2
2 x,
coh2
whereupon
An expression that combines the vari-
ance of the XRF response and the variance
ofthe calibration line is then given:
UPb,=1.462( )Ii + UT i ( c i
2m{ coh ci) coh )4Ix
+b3 + 24
[Gordon 7]
This formula for O2?3b is incorrect in the
fourth term inside the square bracket; this
term should be
JCO \2( )2
mi2
giving a correctedequation of
= 1462[Ci + a ijx ,y
+ + ( coh )(coh)
[Gordon 7 (corrected)]
The typographical error in Equation 7 of
Gordon et al. is propagated through their
Equations 8 and 9. Gordon Equation 8 gave
the variance of the lead concentration
2a Xi -c ch 11Xi 'coh i) coh)(coh)
+ 32 22 2
[Gordon 8 (corrected)]
Similarly, the final term of Gordon
Equation 9, 2
C Ucoh x2
coh
2 4 mi Pbi
should be
( F 2 2
coh )coh)
2 4 miYUPbi
resulting in the corrected version ofGordon
Equation 9:
2()_ 14y + 2 cj
aPb ~~~ 24x 44 2X -c
2a2( X
1 -c Ucoh' ('X N
2 2my Coh-'J) cohJ(coh)
+ M3 24 4
m,UP4b mi 0Pb J
[Gordon 9 (corrected)]
Gordon et al. (3) then pointed out that
"each of the terms (xi/coh) has a mutual
dependence on coh, the coherent scatter
amplitude," and that this dependence can be
accounted for by adding a further term to
Equation Gordon 9 (corrected):
2 x SPb.m=1.46 mIoh . i Ij
cooj mi PbiaPbj
2 (1.46) a, Pb'. m2coh2
Several spectroscopy package regions of
interest give a2 allowing an online estimate
ofOpbito be obtained (assuming the calibra-
tion line slope is already known). An online
estimate ofthe measurement error has been
useful when physicians require rapid assess-
ment ofa patient, and it may prove useful if
a target measurement error is needed for all
subjects. The expression for variance that
accounts for only the X-ray amplitude is
indistinguishable from the expression that
accounts for the variances in both the coher-
ent and the X-ray amplitudes. Table 1 illus-
trates this usingthe dataofGordon et al.
The error arisingfrom covariance.
Equation Gordon 7 warrants further exami-
nation because it contains two assumptions
that are not explicitlystated by Gordon et al.
Equation Gordon 7 is derived from a gener-
alized treatment of error propagation that
can be represented in matrixform (4):
Vy=CaY
= y XY)
dxl dX2 dX3
( varxi coV(xl,x2)
X cov(xI,x2) varx2
COV(x1,x3) COV(X2Xx3)
dy
dx1
X O2 dX2
dy
dx3
cov(x1,x3)
cov(x2,x3)
varx3
where V is the variance in y =f(xl, x2, x3), y coy is the covariance, and var is the variance.
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Upon multiplication:
Vy+=(St I var c(i
+ 2
dy dy
)C°V(Xi,xj)
When I revert from generalized notation
to the notation of Gordon et al. and write
out the summation terms, the result is
a2 2 2
2 UR. + i +(R-CR j -Ci 2
Pbi + m2+ 2 Mi
+(Ri-RCi CJ2
Using
K2 Uch+ ~ XO
( + coh2 ) Xohi= coh22 cimioh
and
Xi
we obtain
(a2i 22 2 2 2
<P=(~ oh2 + oh4 )m2 m
+It ]o,2<2- R2C
2( Xii +Xi 2( X-C
2coh2C ch 2 hIIcoh h2
3 aRim +
x 3
This equation has all of the terms in
Gordon's (corrected) Equation 7 but also
contains two additional terms that involve
the covariance between the response Ri and
the calibration line slope (G7imi) and inter-
cept (ajRici). The unstated assumptions of
Gordon et al. are that both of these covari- ancesarezero:
2 2 =2
2
URimi aR2C
These assumptions are valid and are stated
here only for completeness.
Gordon et al. did not derive the expres-
sion that accounts for the covariance intro-
duced by the mutual dependence of the
ratios ofX-ray-to-coherent amplitudes (R)
on the same coherent peak amplitude. It
may, however, be derived from the product
ofcrude estimates ofGpb from two X-rays i
and j aPbiandoPbj
c2i=1.462 i
m
whereupon
Ifwe then use
2 ('2 X2 2
2 + cobh coh2 coh4
we obtain
1.46
4 2 X 22
= 2 2 2+ m,mm coh coh
2( 2 2
coh2 coh4
[Todd 1]
It may be that Gordon et al. then ignored
all of the terms except the last one in the
bracket (the only one that contains the prod-
uctoftheX-raypeakamplitudes) to obtain:
4 X(X224
2 2 1.46 (XiXjIC0h m2mi coh'
The square root of the expression gives
the termgiven byGordon et al. iftheweight-
ing factors (w?, w) are added and the X-ray
product is evaluated forall pairs ofX-rays
2o x X~X
z 1.462 co,h m,mij
coh4#jM.M.W.Wj
In the notation of Gordon et al., wi =
2pbiand w = = ba making Gordon's actual
expression
142O~
X 22 2 coh i j
chiiij(7Pbi (Pbj
If the assumption about how this term
was derived is correct, there is a potential
problem because the final term ofEquation
Todd 1 is not the largest term. Using the
data ofTableA2 in Gordon et al. (3), Table
2 of this paper shows that the first term,
(2.2./coh4), contributes > 95% of the
value of the whole, whereas the final term
used by Gordon et al. contributes very little
to thevalue ofthewhole.
Table 1. The proportional contribution of the variance in the X-ray peak to the variance in the X-ray-to-
coherentpeak ratiofortwo human subjects measured by Gordon et al.
Subject, peak Coherent al a2 131 P3
Subject B(male)
Amplitudea 2,523 421.5 313.9 81.29 34.61
Amplitude±a 15.16 24.81 38.52 7.399 7.532
Error in peakamplitude (%) 0.601 5.886 12.271 9.102 21.762
Error in peak/coherent(%) - 5.917 12.286 9.122 21.771
(Error in peakamplitude)/ - 99.483 99.880 99.783 99.962
(Error in peak/coherent)(%)
Subject C(female)
Amplitudea 3,436 31.74 85.46 9.106 6.438
Amplitude ±a 17.69 29.96 50.07 8.102 8.442
Error in peakamplitude (%) 0.515 94.392 58.589 88.974 131.128
Error inpeak/coherent(%) - 94.393 58.591 88.976 131.129
(Error in peakamplitude)/ - 99.999 99.996 99.998 99.999
(Error in peak/coherent)(%)
*Datafrom Gordon etal.13),TableA2.
Table 2. The contribution to an expression for the covariance from two terms, aa2.(/coh4 and
xx?a4cohcoh8, expressed as a percentage ofEquationTodd 1 and derived fromthe data ofGordon etal. (3).
Human subjectB' Human subjectc'
Covariance oQ 11 133 o2 131 13
cs2. 2./coh4
alc 98.7 98.5 98.9 98.4 98.1 98.5
a2 - 99.3 99.7 - 99.2 99.6
11 - - 99.5 - 99.3 -
X..Goh/coh8
375x1- a1 3.715 x 10-5 3.708 x 10-5 3.721 x 10-5 3.703 x 10-5 3.692 x 10-5 3.707 x 10-5
a2 - 8.598 x 10-6 8.629 x 10-6 - 8.586 x 10-6 8.621 x 10-6
131 - - 1.565 x 10-5 - 1.563 x105 -
'Percentage contribution tothe total covariance expression.
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Irrespective of the assumption about
how Gordon et al. derived the covariance
term, the quantitative values for the increase
in error arising from the covariance term
reported by Gordon et al. cannot be repro-
duced, probably because ofrounding errors.
TableA2 ofGordon et al. gives the measure-
ment uncertainty resulting from accounting
for the covariance as 0.009 (3.417 - 3.408)
jig Pb/g bone mineral for human subject B.
For Gordon et al. human subject C, the
measurement uncertainty due to the covari-
ance term is 0.00006 (100.0-99.998% of
2.972). My calculation of the contribution
ofthe covariance term directly from the peak
amplitudes given by Gordon et al., but pre-
sumably rounded, is 0.021 and 0.002 pg
Pb/g bone mineral for subjects B and C,
respectively. For Gordon et al.'s high-lead
subject (B), my calculation of the error
increase resulting from adding the covari-
ance term is greater than that calculated by
Gordon et al. by a factor of2.3. For the low-
lead subject (C), my calculations yield an
increase in error 35 times ofthat ofGordon
et al. For both subjects, the covariance cor-
rection is still small. If the differences are
indeed a result ofrounding errors, I question
the use of making a correction to a bone-
lead measurement error that can vary so
much solely as a result ofrounding.
Conclusions
I have corrected typographical errors in the
published method ofGordon et al. (3) and I
provided a crude estimate of measurement
error that may be of some use. I propose
that the correction for the mutual depen-
dence of the X-rays on the coherent peak
not be used because ofthe small size ofthe
covariance correction and the variability due
to rounding.
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